These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24642868)

  • 1. Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study.
    Jensvoll H; Blix K; Brækkan SK; Hansen JB
    PLoS One; 2014; 9(3):e92011. PubMed ID: 24642868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism--the Tromsø study.
    Blix K; Jensvoll H; Brækkan SK; Hansen JB
    PLoS One; 2013; 8(9):e73447. PubMed ID: 24023876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø Study, Tromsø, Norway.
    Braekkan SK; Mathiesen EB; Njølstad I; Wilsgaard T; Størmer J; Hansen JB
    J Thromb Haemost; 2010 Jan; 8(1):157-62. PubMed ID: 19496920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS).
    Riedl J; Kaider A; Reitter EM; Marosi C; Jäger U; Schwarzinger I; Zielinski C; Pabinger I; Ay C
    Thromb Haemost; 2014 Apr; 111(4):670-8. PubMed ID: 24306221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).
    Simanek R; Vormittag R; Ay C; Alguel G; Dunkler D; Schwarzinger I; Steger G; Jaeger U; Zielinski C; Pabinger I
    J Thromb Haemost; 2010 Jan; 8(1):114-20. PubMed ID: 19889150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult cancer-related first venous thromboembolism is associated with an increased risk of recurrent venous thromboembolism.
    Gran OV; Braekkan SK; Paulsen B; Skille H; Rosendaal FR; Hansen JB
    J Thromb Haemost; 2017 Jul; 15(7):1361-1367. PubMed ID: 28440069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet count and risk of major bleeding in venous thromboembolism.
    Johnsen HS; Braekkan SK; Morelli VM; Hansen JB
    Platelets; 2021 May; 32(4):444-452. PubMed ID: 32498591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study.
    Horvei LD; Braekkan SK; Smith EN; Solomon T; Hindberg K; Frazer KA; Rosendaal FR; Hansen JB
    J Thromb Haemost; 2018 Jan; 16(1):83-89. PubMed ID: 29094466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas.
    Thaler J; Ay C; Kaider A; Reitter EM; Haselböck J; Mannhalter C; Zielinski C; Marosi C; Pabinger I
    Neuro Oncol; 2014 Dec; 16(12):1645-51. PubMed ID: 24987133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
    Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
    Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycemia, assessed according to HbA1c , and future risk of venous thromboembolism: the Tromsø study.
    Lerstad G; Brodin EE; Enga KF; Jorde R; Schirmer H; Njølstad I; Svartberg J; Braekkan SK; Hansen JB
    J Thromb Haemost; 2014; 12(3):313-9. PubMed ID: 24382156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical activity and risk of venous thromboembolism. The Tromso study.
    Borch KH; Hansen-Krone I; Braekkan SK; Mathiesen EB; Njolstad I; Wilsgaard T; Hansen JB
    Haematologica; 2010 Dec; 95(12):2088-94. PubMed ID: 20801904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid function, as assessed by TSH, and future risk of venous thromboembolism: the Tromsø study.
    Lerstad G; Enga KF; Jorde R; Brodin EE; Svartberg J; Brækkan SK; Hansen JB
    Eur J Endocrinol; 2015 Jul; 173(1):83-90. PubMed ID: 25899580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study.
    Warny M; Helby J; Birgens HS; Bojesen SE; Nordestgaard BG
    J Thromb Haemost; 2019 Nov; 17(11):1898-1911. PubMed ID: 31309714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cigarette smoking and the risk of venous thromboembolism: the Tromsø Study.
    Enga KF; Braekkan SK; Hansen-Krone IJ; le Cessie S; Rosendaal FR; Hansen JB
    J Thromb Haemost; 2012 Oct; 10(10):2068-74. PubMed ID: 22882779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of platelet activation markers with cancer-associated venous thromboembolism.
    Riedl J; Hell L; Kaider A; Koder S; Marosi C; Zielinski C; Panzer S; Pabinger I; Ay C
    Platelets; 2016; 27(1):80-5. PubMed ID: 25970326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function--the Tromsø study.
    Brodin EE; Brækkan SK; Vik A; Brox J; Hansen JB
    Haematologica; 2012 Jul; 97(7):1008-13. PubMed ID: 22315498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carotid atherosclerosis predicts future myocardial infarction but not venous thromboembolism: the Tromso study.
    Hald EM; Lijfering WM; Mathiesen EB; Johnsen SH; Løchen ML; Njølstad I; Wilsgaard T; Rosendaal FR; Brækkan SK; Hansen JB
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):226-30. PubMed ID: 24177328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism increases the risk of atrial fibrillation: the Tromso study.
    Hald EM; Enga KF; Løchen ML; Mathiesen EB; Njølstad I; Wilsgaard T; Braekkan SK; Hansen JB
    J Am Heart Assoc; 2014 Jan; 3(1):e000483. PubMed ID: 24385452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
    Ferroni P; Riondino S; Formica V; Cereda V; Tosetto L; La Farina F; Valente MG; Vergati M; Guadagni F; Roselli M
    Int J Cancer; 2015 Mar; 136(5):1234-40. PubMed ID: 25042739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.